SABBY MANAGEMENT LLC
Q3 2025 Form 13-F

SPICEWOOD, TEXAS
CIK 0001535610 · CRD 162659 · Exempt reporting adviser
Consolidated report · includes 1 manager since Q3 2024
$86.4M Reported Value Total
Exempt Reporting Adviser Discretionary Manager
Private funds (Form ADV)
2 funds · $197.4M gross asset value
Private Equity Fund: $181.5M · Hedge Fund: $15.8M
Source: Form ADV filed 2026-07-08
Reported value
$86.4M
Quarter over quarter
-38.2%
Holdings
29
Top-10 concentration
91.3%

Filing Structure

Reports holdings for

  • Hal Mintz (not a 13F filer in our records) · since Q3 2024 · declared by one filing
  • Mintz Hal · File #028-13502 · Q2 2013 – Q1 2025 · declared by one filing

Key People

Form ADV owners & control persons
Hal David Mintz
PRINCIPAL AND MANAGING MEMBER OF SABBY MANAGEMENT, LLC AND SABBY CAPITAL, LLC
Robert Alan Grundstein
CHIEF COMPLIANCE OFFICER OF SABBY MANAGEMENT, LLC AND SABBY CAPITAL, LLC

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2025 13F record

Q3 2025 13F filing summary

Q3 2025 Form 13F portfolio summary
Period of report September 30, 2025
Filed November 14, 2025
Form 13F-HR
Reported value $86.4M
Positions 29
Change in reported value +56.8%
New positions 23
Exited positions 27
Position turnover 89.3%
Top-10 concentration 91.3%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 13, 2026
14 $9.0M
Q2 2026 13F
Filed Aug 14, 2026
16 $110.5M
Q1 2026 13F
Filed May 15, 2026
22 $45.1M
Q4 2025 13F
Filed Feb 17, 2026
25 $69.5M
Q3 2025 13F
Filed Nov 14, 2025
29 $86.4M
Q2 2025 13F
Filed Aug 14, 2025
33 $55.1M
Q1 2025 13F
Filed May 15, 2025
36 $34.0M
Q4 2024 13F
Filed Feb 14, 2025
16 $76.9M
Q3 2024 13F
Filed Nov 14, 2024
27 $186.4M
Q2 2024 13F
Filed Aug 14, 2024
27 $148.7M
Q1 2024 13F
Filed May 15, 2024
43 $173.3M
Q4 2023 13F
Filed Feb 14, 2024
46 $100.0M
Q3 2023 13F
Filed Nov 14, 2023
66 $136.6M
Q2 2023 13F
Filed Aug 14, 2023
68 $122.2M
Q1 2023 13F
Filed May 15, 2023
72 $114.8M
Q4 2022 13F
Filed Feb 14, 2023
89 $114.0M
Q3 2022 13F
Filed Nov 14, 2022
82 $79.3M
Q2 2022 13F
Filed Aug 15, 2022
75 $147.0M
Q1 2022 13F
Filed May 16, 2022
83 $669.7M
Q4 2021 13F
Filed Feb 14, 2022
103 $687.8M

34 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q3 2025

Largest Q3 2025 13F positions by reported value
# Holding Reported value % of portfolio
1 NYC C ISHARES TR $20.2M 23.34%
2 SPY P SPDR S&P 500 ETF $17.3M 19.96%
3 NYC P ISHARES TR $17.0M 19.7%
4 DSY BIG TREE CLOUD HOLDINGS LTD $8.0M 9.29%
5 SPY C SPDR S&P 500 ETF $7.9M 9.09%
6 EOSE P EOS ENERGY ENTERPRISES INC $4.0M 4.62%
7 EMPD EMPERY DIGITAL INC $1.7M 1.96%
8 CPOP POP CULTURE GROUP CO LTD $1.1M 1.26%
9 EVEX EVE HLDG INC $885.7K 1.02%
10 CANF CAN-FITE BIOPHARMA LTD $870.6K 1.01%
11 LYRA LYRA THERAPEUTICS INC $832.9K 0.96%
12 SVRN OCEANPAL INC $822.8K 0.95%
13 LMFA LM FDG AMER INC $727.6K 0.84%
14 BIAF BIOAFFINITY TECHNOLOGIES INC $718.6K 0.83%
15 UCAR U POWER LTD $485.3K 0.56%
16 INM INMED PHARMACEUTICALS INC $481.8K 0.56%
17 EEIQ EPICQUEST EDUCATN GRP INTL $400.8K 0.46%
18 SNES SENESTECH INC $312.9K 0.36%
19 GOVX GEOVAX LABS INC $312.9K 0.36%
20 ZVRA P ZEVRA THERAPEUTICS INC $311.0K 0.36%

Values as reported on the Q3 2025 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings